Single stage and multistage classification models for the prediction of liver fibrosis degree in patients with chronic hepatitis C infection

Predicting significant fibrosis or cirrhosis in patients with hepatitis C virus has persistently preoccupied the research agenda of many specialized research centers. Many studies have been conducted to evaluate the use of readily available laboratory tests to predict significant fibrosis or cirrhosis with the purpose to substantially reduce the number of biopsies performed. Although many of them reported significant predictive values of several serum markers for the diagnosis of cirrhosis, none of these diagnostic techniques was successful in accurately predicting early stages of liver fibrosis. Therefore, in this study a single stage classification model and a multistage stepwise classification model based on Neural Network, Decision Tree, Logistic Regression, and Nearest Neighborhood clustering, have been developed to predict individual's liver fibrosis degree. Results showed that the area under the receiver operator curve (AUROC) values of the multistage model ranged from 0.874 to 0.974 which is a higher range than what is reported in current researches with similar conditions.

[1]  Patrick Shannon,et al.  Business Statistics: A Decision-Making Approach , 1981 .

[2]  V. Paradis,et al.  Sampling variability of liver fibrosis in chronic hepatitis C , 2003, Hepatology.

[3]  Massimo Pinzani,et al.  Technology Insight: noninvasive assessment of liver fibrosis by biochemical scores and elastography , 2008, Nature Clinical Practice Gastroenterology &Hepatology.

[4]  Mohamed Abdel-Hamid,et al.  Incidence and risk factors for hepatitis C infection in a cohort of women in rural Egypt. , 2008, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[5]  T. Poynard,et al.  Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study , 2001, The Lancet.

[6]  Giorgio Palù,et al.  Short statement of the first European Consensus Conference on the treatment of chronic hepatitis B and C in HIV co-infected patients. , 2005, Journal of hepatology.

[7]  Dumitru Dumitrescu,et al.  An Evolutionary Approximation for the Coefficients of Decision Functions within a Support Vector Machine Learning Strategy , 2009, Foundations of Computational Intelligence.

[8]  John P. Iredale,et al.  Inhibition of Apoptosis of Activated Hepatic Stellate Cells by Tissue Inhibitor of Metalloproteinase-1 Is Mediated via Effects on Matrix Metalloproteinase Inhibition , 2002, The Journal of Biological Chemistry.

[9]  Qinghui Wang,et al.  Identification of the risk for liver fibrosis on CHB patients using an artificial neural network based on routine and serum markers , 2010, BMC infectious diseases.

[10]  D. Roulot,et al.  Transforming growth factor β and the liver , 2001 .

[11]  E. Schiff,et al.  Measurement of serum hyaluronic acid in patients with chronic hepatitis C and its relationship to liver histology , 2000, Journal of gastroenterology and hepatology.

[12]  E. Schiff,et al.  Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection , 2002, American Journal of Gastroenterology.

[13]  M. Abdel-hamid,et al.  Optimization, assessment, and proposed use of a direct nested reverse transcription-polymerase chain reaction protocol for the detection of hepatitis C virus. , 1997, Journal of human virology.

[14]  S Chevret,et al.  Biochemical markers of liver fibrosis in patients infected by hepatitis C virus: longitudinal validation in a randomized trial , 2002, Journal of viral hepatitis.

[15]  A. Way,et al.  Egypt Demographic and Health Survey 2000. , 2009 .

[16]  Daniela Manuc,et al.  Methods for Data Selection in Medical Databases: The Binary Logistic Regression -Relations with the Calculated Risks , 2008 .

[17]  Y. Alp Aslandogan,et al.  Evidence combination in medical data mining , 2004, International Conference on Information Technology: Coding and Computing, 2004. Proceedings. ITCC 2004..

[18]  N. Afdhal,et al.  Perspectives on Fibrosis Progression in Hepatitis C: An à la Carte Approach to Risk Factors and Staging of Fibrosis , 2010, Antiviral therapy.

[19]  Man-Fung Yuen,et al.  Viral hepatitis B , 2003, The Lancet.

[20]  Fernando Martin-Sanchez,et al.  An artificial neural network improves the non-invasive diagnosis of significant fibrosis in HIV/HCV coinfected patients. , 2011, The Journal of infection.

[21]  Gamal Esmat,et al.  Evaluation of serum biomarkers of fibrosis and injury in Egyptian patients with chronic hepatitis C. , 2007, Journal of hepatology.

[22]  Reza Malekzadeh,et al.  Serum hyaluronate as a non-invasive marker of hepatic fibrosis and inflammation in HBeAg-negative chronic hepatitis B , 2005, BMC gastroenterology.

[23]  Yoram Singer,et al.  Reducing Multiclass to Binary: A Unifying Approach for Margin Classifiers , 2000, J. Mach. Learn. Res..

[24]  F. Degos,et al.  Practices of Liver Biopsy in France: Results of a Prospective Nationwide Survey , 2000, Hepatology.

[25]  Nigel Crook,et al.  Using input parameter influences to support the decisions of feedforward neural networks , 1999, Neurocomputing.

[26]  D M Bissell,et al.  Transforming growth factor beta and the liver. , 2001, Hepatology.

[27]  N. Afdhal,et al.  Evaluation of Liver Fibrosis: A Concise Review , 2004, American Journal of Gastroenterology.

[28]  Florin Gorunescu,et al.  Data Mining Techniques in Computer-Aided Diagnosis: Non-Invasive Cancer Detection , 2007 .

[29]  Y Ikuta,et al.  Clinical usefulness of serum tissue inhibitor of metalloproteinases (TIMP)-2 assay in patients with chronic liver disease in comparison with serum TIMP-1. , 1999, Clinica chimica acta; international journal of clinical chemistry.

[30]  Ruxandra Stoean,et al.  Evolutionary-driven support vector machines for determining the degree of liver fibrosis in chronic hepatitis C , 2011, Artif. Intell. Medicine.

[31]  HiroshiSakugawa,et al.  Clinical usefulness of biochemical markers of liver fibrosis in patients with nonalcoholic fatty liver disease , 2005 .

[32]  S. Friedman Molecular Regulation of Hepatic Fibrosis, an Integrated Cellular Response to Tissue Injury* , 2000, The Journal of Biological Chemistry.

[33]  Albert Tran,et al.  Accuracy of hyaluronic acid level for predicting liver fibrosis stages in patients with hepatitis C virus , 2005, Comparative hepatology.

[34]  Samer S El-Kamary,et al.  Role of liver biopsy in management of chronic hepatitis C: A systematic review , 2002, Hepatology.

[35]  Bruno Crémilleux,et al.  Search for factors estimating the stage of liver fibrosis based on the discovery of meaningful clusters , 2002 .

[36]  Jaideep Srivastava,et al.  Feature Mining for Prediction of Degree of Liver Fibrosis , 2005, AMIA.